Professor and Chief, Division of Vascular and Endovascular Surgery
University of California San Francisco
San Francisco, California
Dr. Michael S. Conte is Professor and Chief of Vascular and Endovascular Surgery at the University of California, San Francisco (UCSF) Medical Center, and holds the E.J Wylie Chair in Vascular Surgery. He also serves as Co-Director of the UCSF Heart and Vascular Center, Director of the Noninvasive Vascular Laboratory, Co-Director of the UCSF Center for Limb Preservation, and Program Director of the vascular integrated residency and fellowships at UCSF.
Dr. Conte’s clinical interests include diseases of the aorta, carotid artery, and peripheral artery disease (PAD). He is particularly interested in diabetic vascular disease, and in complex revascularization in patients with limb-threatening ischemia. Dr. Conte led the PREVENT-3 clinical trial in vein bypass surgery for severe PAD and has played a leading role in clinical practice guidelines including the SVS practice guideline on claudication and the Global Vascular Guideline on the management of chronic limb-threatening ischemia.
As a career surgeon-scientist, Dr. Conte’s translational research is focused on the biology of vascular injury and improving the healing response of blood vessels. His work has been continuously funded by the National Institutes of Health for >2 decades. He has authored more than 250 publications spanning from basic to clinical science. Dr. Conte is a past- president of the Western Vascular Society, and a past Chair of the American Heart Association Council on Peripheral Vascular Disease. He serves as Chief Medical Officer of the non-profit foundation Vascular Cures.
Expanding the Vascular Surgeons Toolbox: Bringing Vascular Wound Research to Your Practice
Wednesday, June 14, 2023
2:30 PM – 2:40 PM ET
VESS10 - Perioperative Systemic Complications and Adverse Events in the BEST-CLI Trial
Wednesday, June 14, 2023
2:42 PM – 2:53 PM ET
Thursday, June 15, 2023
8:11 AM – 8:22 AM ET
Thursday, June 15, 2023
8:23 AM – 8:34 AM ET
Thursday, June 15, 2023
8:51 AM – 8:58 AM ET
VH03 - Carotid Body Tumor Resection
Thursday, June 15, 2023
3:48 PM – 3:57 PM ET
Debate: Patients with CLTI Who Have Adequate Saphenous Vein Should be Treated with Bypass
Thursday, June 15, 2023
3:51 PM – 3:58 PM ET